MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2025 International Congress

    Assessing the potential association of rs2298383 in ADORA2A as a predictor of Levodopa-Induced Dyskinesia in Latin American Parkinson’s Disease patients

    HM. Chaparro-Solano, E. Waldo, T. Peixoto-Leal, AF. Schumacher-Schuh, BL. Santos-Lobato, E. Gatto, G. Arboleda, JL. Orozco-Velez, P. Chana-Cuevas, D. Aguillon, M. Rodriguez-Violante, D. Martinez-Ramirez, M. Cornejo-Olivas, A. Vinuela, G. Alvarado, P. Olguín, S. Alcauter, IF. Mata (Cleveland, USA)

    Objective: To analyze the association between ADORA2A-rs2298383 and levodopa induced dyskinesias (LID) in a cohort of Latin American Parkinson’s disease patients. Background: Previous evidence has…
  • 2025 International Congress

    Insights into Genetic Counseling Recall and Clinical Trial Interest in PD GENEration

    S. Rao, M. Murray, L. Caboy, R. de Leon, L. Desnoyers, M. Dini, K. Ghosh Galvelis, J. Beck, R. Alcalay (Miami, USA)

    Objective: To assess the impact of participation in PD GENEration, a large-scale genetic and counseling study for Parkinson’s disease (PD). We evaluated the recall of…
  • 2025 International Congress

    Linking Adolescent Brain Development To Parkinson’s Disease Risk Using Machine Learning On Polygenic Risk Scores

    L. Liu, R. Zhu, E. Yu, X. Liu, R. Ge, A. Dagher, Z. Gan-Or (Montreal, Canada)

    Objective: Examine whether adolescent brain structural deviations contribute to Parkinson’s disease (PD) susceptibility. Background: Genetic variants associated with PD have been linked to neurodevelopmental processes,…
  • 2025 International Congress

    Improving Recruitment of Black and African American Participants in Parkinson’s Genetics Research

    N. Louie, C. Kelliher, MN. Dean, D. Hall, EA. Shamim, T. Xie, E. Disbrow, A. Rawls, A. Ameri, S. Chandra, E. Foster, V. Hinson, C. Kilbane, S. Norris, L. Shulman, J. Staisch, LM. Chahine (New York, USA)

    Objective: To describe recruitment methods and lessons learned to date in the BLAAC PD study. Background: Diversity in Parkinson’s disease (PD) research is largely lacking.…
  • 2025 International Congress

    The Role of Polygenic Background and APOE E4 in Monogenic and Idiopathic Parkinson’s Disease

    M. Kmiecik, M. Holmes, P. Fontanillas, G. Riboldi, R. Schneider, J. Shi, A. Guan, S. Tat, K. Stagaman, J. Gottesman, D. Hinds, J. Tung, S. Aslibekyan, L. Norcliffe-Kaufmann (Sunnyvale, USA)

    Objective: To assess the impact of 1) polygenic risk scores (PRS) on monogenic Parkinson’s disease (PD) risk and time to diagnosis and 2) APOE E4…
  • 2025 International Congress

    Magnetic Resonance Guided Focused Ultrasound for Essential Tremor and Tremor dominant Parkinson’s Disease Case Series

    M. Jayasree, M. Panigrahi, G. Gorrepati (Hyderabad, India)

    Objective: To assess the efficacy and safety of Magnetic Resonance Guided Focused Ultrasound (MRgFUS) for Essential Tremor (ET) and Tremor Dominant Parkinson's Disease (TDPD) in…
  • 2025 International Congress

    Minimally Invasive Magnetic Resonance Imaging guided Deep Brain Stimulation for Movement Disorders – A Novel technique, Accuracy and Clinical Outcome.

    J. Shah, F. Panov (NEW YORK, USA)

    Objective: To study the accuracy of lead placement and clinical outcome of a novel technique using twist drill hole and smaller incision in Magnetic resonance…
  • 2025 International Congress

    Full-year Open-label Tracking of Adaptive Deep Brain Stimulation in Parkinson’s Disease in Two Patients: Considerations for Long-term Algorithm Maintenance

    J. Yao, M. Shcherbakova, A. Hahn, L. Hammer, S. Cernera, C. Oehrn, S. Little, P. Starr (San Francisco, USA)

    Objective: To assess the effects of chronic adaptive deep brain stimulation (aDBS) on motor symptoms and quality of life (QoL) and algorithm stability in two…
  • 2025 International Congress

    EEG Correlates of Orthostatic Hypotension in Parkinson’s Disease: Novel Biomarkers for Autonomic Failure

    A. Frohlich, J. Riddle, F. Frohlich, D. Rubinow, E. Dayan, M. Sklerov (Chapel Hill, USA)

    Objective: To identify potential EEG biomarkers associated with orthostatic hypotension in Parkinson Disease (PD) and evaluate their relationship with clinical measures of autonomic dysfunction. Background:…
  • 2025 International Congress

    The First cross-sectional comparative observational study of Sexual Dysfunction in Emirati and non-Emirati Parkinson’s disease Patients (EmPark-SD) in the United Arab Emirates

    V. Metta, H. Benamer, T. Loney, H. Hussain, A. Nalarakettil, E. Awad, S. Kumar, C. Falup, R. Borgohain, R. Chaudhuri (London, United Kingdom)

    Objective: The objective of our study was to investigate the demographic and clinical characteristics, as well as the confounding factors associated with sexual dysfunction in…
  • « Previous Page
  • 1
  • …
  • 47
  • 48
  • 49
  • 50
  • 51
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley